Old Web
SPM-927 (Schwarz Pharma).
2003
Abstract Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
50
Citations
NaN
KQI